Literature DB >> 9763490

Correlative ultrastructural distribution of neurotensin receptor proteins and binding sites in the rat substantia nigra.

H Boudin1, D Pélaprat, W Rostène, V M Pickel, A Beaudet.   

Abstract

Neurotensin (NT) produces various stimulatory effects on dopaminergic neurons of the rat substantia nigra. To gain insight into the subcellular substrate for these effects, we compared by electron microscopy the distribution of immunoreactive high-affinity NT receptor proteins (NTRH) with that of high-affinity 125I-NT binding sites in this region of rat brain. Quantitative analysis showed a predominant association of immunogold and radioautographic labels with somata and dendrites of presumptive dopaminergic neurons, and a more modest localization in myelinated and unmyelinated axons and astrocytic leaflets. The distributions of immunoreactive NTRH and 125I-NT binding sites along somatodendritic plasma membranes were highly correlated and homogeneous, suggesting that membrane-targeted NTRH proteins were functional and predominantly extrasynaptic. Abundant immunocytochemically and radioautographically labeled receptors were also detected inside perikarya and dendrites. Within perikarya, these were found in comparable proportions over membranes of smooth endoplasmic reticulum and Golgi apparatus, suggesting that newly synthesized receptor proteins already possess the molecular and conformational properties required for effective ligand binding. By contrast, dendrites showed a proportionally higher concentration of immunolabeled than radiolabeled intracellular receptors. A fraction of these immunoreactive receptors were found in endosomes, suggesting that they had undergone ligand-induced internalization and were under a molecular conformation and/or in a physical location that precluded their recognition by and/or access to exogenous ligand. Our results provide the first evidence that electron microscopic immunocytochemistry of the NT receptor identifies sites for both the binding and trafficking of NT in the substantia nigra.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9763490      PMCID: PMC6792847     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  57 in total

1.  Target-cell-specific concentration of a metabotropic glutamate receptor in the presynaptic active zone.

Authors:  R Shigemoto; A Kulik; J D Roberts; H Ohishi; Z Nusser; T Kaneko; P Somogyi
Journal:  Nature       Date:  1996-06-06       Impact factor: 49.962

2.  Correspondence between high affinity 125I-neurotensin binding sites and dopaminergic neurons in the rat substantia nigra and ventral tegmental area: a combined radioautographic and immunohistochemical light microscopic study.

Authors:  E Szigethy; A Beaudet
Journal:  J Comp Neurol       Date:  1989-01-01       Impact factor: 3.215

3.  Ultrastructural localization of neurotensin-like immunoreactivity within dense core vesicles in perikarya, but not terminals, colocalizing tyrosine hydroxylase in the rat ventral tegmental area.

Authors:  V E Bayer; A C Towle; V M Pickel
Journal:  J Comp Neurol       Date:  1991-09-08       Impact factor: 3.215

4.  Role of the nuclear envelope in synthesis, processing, and transport of membrane glycoproteins.

Authors:  L Puddington; M O Lively; D S Lyles
Journal:  J Biol Chem       Date:  1985-05-10       Impact factor: 5.157

5.  Behavioral analysis of the effect of neurotensin injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat.

Authors:  M Cador; A E Kelley; M Le Moal; L Stinus
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1 alpha, mGluR2 and mGluR5, relative to neurotransmitter release sites.

Authors:  R Luján; J D Roberts; R Shigemoto; H Ohishi; P Somogyi
Journal:  J Chem Neuroanat       Date:  1997-10       Impact factor: 3.052

7.  Neurotensin causes a greater increase in the metabolism of dopamine in the accumbens than in the striatum in vivo.

Authors:  R Rivest; F B Jolicoeur; C A Marsden
Journal:  Neuropharmacology       Date:  1991-01       Impact factor: 5.250

8.  Occurrence of neurotensinlike immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons.

Authors:  T Hökfelt; B J Everitt; E Theodorsson-Norheim; M Goldstein
Journal:  J Comp Neurol       Date:  1984-02-01       Impact factor: 3.215

9.  Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain.

Authors:  J Mazella; J M Botto; E Guillemare; T Coppola; P Sarret; J P Vincent
Journal:  J Neurosci       Date:  1996-09-15       Impact factor: 6.167

10.  Expression of a rat neurotensin receptor in Escherichia coli.

Authors:  R Grisshammer; R Duckworth; R Henderson
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

View more
  27 in total

1.  Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus.

Authors:  J J Rodriguez; K Mackie; V M Pickel
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

2.  Dopamine D3 receptors expressed by all mesencephalic dopamine neurons.

Authors:  J Diaz; C Pilon; B Le Foll; C Gros; A Triller; J C Schwartz; P Sokoloff
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

3.  Sex Differences in the Rat Hippocampal Opioid System After Oxycodone Conditioned Place Preference.

Authors:  James D Ryan; Yan Zhou; Natalina H Contoreggi; Farah K Bshesh; Jason D Gray; Joshua F Kogan; Konrad T Ben; Bruce S McEwen; Mary Jeanne Kreek; Teresa A Milner
Journal:  Neuroscience       Date:  2018-10-11       Impact factor: 3.590

4.  NMDA Receptor Plasticity in the Hypothalamic Paraventricular Nucleus Contributes to the Elevated Blood Pressure Produced by Angiotensin II.

Authors:  Michael J Glass; Gang Wang; Christal G Coleman; June Chan; Evgeny Ogorodnik; Tracey A Van Kempen; Teresa A Milner; Scott D Butler; Colin N Young; Robin L Davisson; Costantino Iadecola; Virginia M Pickel
Journal:  J Neurosci       Date:  2015-07-01       Impact factor: 6.167

Review 5.  Neurotensin in reward processes.

Authors:  María Luisa Torruella-Suárez; Zoe A McElligott
Journal:  Neuropharmacology       Date:  2020-02-11       Impact factor: 5.250

6.  Sex Differences in the Subcellular Distribution of Corticotropin-Releasing Factor Receptor 1 in the Rat Hippocampus following Chronic Immobilization Stress.

Authors:  Helena R McAlinn; Batsheva Reich; Natalina H Contoreggi; Renata Poulton Kamakura; Andreina G Dyer; Bruce S McEwen; Elizabeth M Waters; Teresa A Milner
Journal:  Neuroscience       Date:  2018-05-26       Impact factor: 3.590

7.  Nuclear and extranuclear estrogen binding sites in the rat forebrain and autonomic medullary areas.

Authors:  Teresa A Milner; Laura S Lubbers; Stephen E Alves; Bruce S McEwen
Journal:  Endocrinology       Date:  2008-03-20       Impact factor: 4.736

8.  Deletion of the NMDA-NR1 receptor subunit gene in the mouse nucleus accumbens attenuates apomorphine-induced dopamine D1 receptor trafficking and acoustic startle behavior.

Authors:  Michael J Glass; Danielle C Robinson; Elizabeth Waters; Virginia M Pickel
Journal:  Synapse       Date:  2013-03-05       Impact factor: 2.562

9.  The neurokinin-3 (NK3) and the neurokinin-1 (NK1) receptors are differentially targeted to mesocortical and mesolimbic projection neurons and to neuronal nuclei in the rat ventral tegmental area.

Authors:  Andrée Lessard; Martin Savard; Fernand Gobeil; Joseph P Pierce; Virginia M Pickel
Journal:  Synapse       Date:  2009-06       Impact factor: 2.562

10.  Sex differences in NMDA GluN1 plasticity in rostral ventrolateral medulla neurons containing corticotropin-releasing factor type 1 receptor following slow-pressor angiotensin II hypertension.

Authors:  T A Van Kempen; M Dodos; C Woods; J Marques-Lopes; N J Justice; C Iadecola; V M Pickel; M J Glass; T A Milner
Journal:  Neuroscience       Date:  2015-08-22       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.